Curesign
PrivateLast Round
Seed
Feb 1, 2020
Company Overview
Curesign is a therapeutic devices company that develops medical devices designed to optimize oncology treatments.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Precision Medicine, Medical AI, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curesign Comparables
Compare Curesign with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoHost | 66% | |
| Adiposs | 59% | |
| VieCure | 57% |
Curesign Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 1, 2020 |
Curesign Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Peregrine Ventures | Seed |
| Nacre Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2020
Raised capital from Nacre Capital and Peregrine Ventures.
Curesign Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Curesign's valuation, stock price, and market status.
Is Curesign a public or private company?
Curesign is a private company.
What is the current stock price of Curesign?
Curesign is a private company, so its shares have no public market price. Caplight tracks Curesign's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Curesign worth (valuation)?
Valuation information for Curesign is not publicly available.
Can I buy Curesign stock?
Curesign shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Curesign's last funding round?
Curesign's most recent funding round was Seed on February 1, 2020.
Who are the main investors in Curesign?
Key investors in Curesign include Peregrine Ventures, Nacre Capital.
Will Curesign IPO soon?
No public IPO plans have been announced for Curesign.
How can I track Curesign secondary market activity?
Caplight tracks bids, offers, and trades in Curesign's shares on secondary markets.